Patent assignee · FR · COMPANY

Moraine Corporation

37Patents
30Active
37Granted
54Portfolio score

Filing activity: Feb 22, 1982 → Sep 8, 2023 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US5777576A Apparatus and methods for non impact imaging and digital printing Physics 48 Expired
US5038797A Electrical stimulation treatment device and method of use Human Necessities 38 Expired
USD858113S1 Material for decorative wrapping General 12 Active
US4409131A Preparation of CoMo and NiMo catalyst using cobalt or nickel complexes that are stable in basic solution Performing Operations; Transporting 12 Expired
US8339968B2 Transient video anomaly analysis and reporting system Electricity 10 Active
USD891788S1 Material for decorative wrapping General 10 Active
US4587571A Read and erase device Physics 5 Expired
US5508727A Apparatus and method for pattern generation on a dielectric substrate Electricity 4 Expired
US10435665B2 Method of culturing segmented filamentous bacteria in vitro Emerging Cross-Sectional Technologies 3 Active
US10336520B2 Single-ply, non-corrugated materials suitable for decorative wrapping Performing Operations; Transporting 3 Active
US6619128B1 Pressure gauge for toy water gun Physics 3 Expired
US10338559B2 Methods and system for reducing energy use in buildings Emerging Cross-Sectional Technologies 2 Active
USD931547S1 Eye guard for a medical mask General 2 Active
US11673714B2 Card packaging system Performing Operations; Transporting 1 Active
US5767885A Apparatus and method for pattern generation on a dielectric substrate Physics 1 Expired
US9377471B2 Methods and compositions for the treatment of β-thalassemia Physics 1 Active
US9325986B2 Transient video anomaly analysis and reporting system Electricity 1 Active
US9675590B2 Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes Human Necessities 0 Active
US11157945B2 Marketing management system Physics 0 Active
US11857532B2 Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxia Human Necessities 0 Active
US11061376B2 Methods and system for reducing energy use in buildings Emerging Cross-Sectional Technologies 0 Active
US11357778B2 Antagonist of the fibroblast growth factor receptor 3 (FGFR3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of FGFR3 Chemistry; Metallurgy 0 Active
US12257232B2 Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias Human Necessities 0 Active
US10647752B2 Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1 Chemistry; Metallurgy 0 Active
US11389434B2 Methods and pharmaceutical compositions for the treatment of mast cell diseases Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.